Growth hormones with prolonged in-vivo efficacy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9695226
SERIAL NO

13522390

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to growth hormone compounds with a protracted profile. The effect is obtained by linking an albumin binding residue via a hydrophilic spacer to growth hormone variants. Further described are methods of preparing and using such compounds. These growth hormone compounds are based on there altered profile considered particular useful in therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVO NORDISK HEALTHCARE AGTHURGAUERSTRASSE 36/38 ZURICH CH-8050

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andersen, Henrik Sune Holte, DK 89 1132
Behrens, Carsten Koebenhavn N, DK 72 703
Buchardt, Jens Gentofte, DK 25 78
Johansen, Nils Langeland Koebenhavn Oe, DK 40 650
Noerskov-Lauritsen, Leif Tappernoeje, DK 12 40

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 4, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00